Facial Rejuvenation Market Research Report - Global Forecast till 2030

Facial Rejuvenation Market Research Report: By Product Type (Botulinum Toxin, Dermal Fillers, Chemical Peels, Topical Skin Care Products, Skin Rejuvenation Devices) and By End-User (Hospitals and Clinics, Dermatology Clinics, Others) ‚Äď Forecast to 2030

ID: MRFR/HC/7339-HCR | 90 Pages | Published By Kinjoll Dey on March 2023         

Facial Rejuvenation Market

Facial rejuvenation market is expected to reach USD26.36 Million at 20.65.7.10% CAGR by 2030.

Segmentation
By Product Type Botulinum Toxin Dermal Fillers Chemical Peels Topical Skin Care Products Skin Rejuvenation Devices
By End-User Hospitals and Clinics Dermatology Clinics
Key Players
Companies Profiled   Allergan (Ireland)   Merz Pharma (Germany)   Galderma (Switzerland)   Lumenis (US)   Revance (US)   Contura Ltd (US)   Anika Therapeutics Inc. (US)   Fibrocell Science Inc. (US)   Cynosure   A Hologic Company (US)
Drivers
Market Driving Forces   Cost-effective alternative to cosmetic surgeries.   Rising demand for non-invasive aesthetic procedures.   Increasing R&D expenditure by companies to develop advanced treatments
Request a Free Sample

Market Synopsis


Facial rejuvenation market is expected to reach USD at 7.10% CAGR by 2030. Facial rejuvenation is a type of cosmetic treatment that uses non-invasive or minimally invasive procedures to restore the skin elasticity and improve the appearance of the skin. Growing demand for non-invasive aesthetic procedures, technological advancements by market players and changing lifestyle of the urban population are the key factors that are expected to drive the market growth. Moreover, the rising demand for quick results & shorter treatment durations and increasing popularity & awareness regarding facial rejuvenation are also expected to boost market growth.


Facial Rejuvenation Market Influencer


The increasing popularity of facial rejuvenation over invasive cosmetic procedures is expected to increase the demand for procedures.


Facial Rejuvenation Market Drivers



  • Cost-effective alternative to cosmetic surgeries. In comparison to cosmetic surgeries, dermal fillers prove to be more reliable, affordable, and cost-effective. In 2018, the fees incurred by practitioners for facelift surgery was about USD 7,655, whereas, fees for facial rejuvenation using hyaluronic acid was just USD 682 in the US. This data demonstrates that fees of dermal fillers are quite low when compared to surgery, thus, increasing the preferability rates of dermal fillers.



  • Rising demand for non-invasive aesthetic procedures



  • Increasing R&D expenditure by companies to develop advanced treatments



  • Change in the lifestyle of the urban population



  • Rising demand for quick results and shorter treatment durations



  • Growing awareness and popularity regarding facial rejuvenation



  • Deeper penetration of cosmetic products in the local markets


Facial Rejuvenation Market Restraints



  • Side effects associated with dermal fillers

  • Lack of skilled professionals

  • Growing availability of fraudulent products

  • Lack of knowledge regarding product efficacy

  • Improper standardization of regulations


Facial Rejuvenation Market Segmentation


By Product Type



  • Botulinum Toxin: Increasing the number of product approvals and rising acceptance of botulinum toxin by consumers is expected to drive the market growth for the segment.



  • Dermal Fillers: This segment held the largest market share in 2018 owing to its growing demand globally, increasing use of dermal fillers by the cosmetic surgeons, and its cost-effectiveness over other alternatives. Dermal Fillers are further segmented into hyaluronic acid, polymers & particles, calcium hydroxyapatite, and collagen.



  • Chemical Peels: The rising popularity of chemical peels due to its regenerative effect on the skin is anticipated to drive the market growth.



  • Topical Skin Care Products: Easy accessibility and usage over other products is expected to drive the market growth



  • Skin Rejuvenation Devices: Technological advancements, wide adoption in the cosmetic industry, and long-lasting effects of the procedures are anticipated to drive the market growth. This segment is further segmented into intense pulsed light, microdermabrasion, laser-based devices, and ultrasound.


By End-User



  • Hospitals and Clinics: This segment is expected to grow significantly, owing to the rising patient population.



  • Dermatology Clinics: This segment is expected to demonstrate the fastest growth owing to its increasing popularity in developing countries.



  • Others: This includes research and academic instituted and beauty centers, among others.


By Region



  • Americas: The largest regional market. Increase in the number of minimally invasive cosmetic procedures, high per capita disposable income, and increasing awareness about procedures related to dermal fillers. For instance, in 2017, about 17.5 million surgical and minimally invasive cosmetic procedures were performed in the US, with a 2% increase in the number of procedures over 2016. Thus, the demand for facial rejuvenation procedures has been increasing in the region, hence driving the market growth.



  • Europe: The Facial Rejuvenation market in Europe held the second-largest position in 2018 owing to the increasing acceptance of new aesthetic products and the increasing number of product approvals & availability of products across the region.



  • Asia-Pacific: The fastest-growing regional market. The growth of the facial rejuvenation market in this region is owing to rising per capita disposable income, escalating demand of facial aesthetics products, and increasing awareness about non-invasive cosmetic procedures available in the market.



  • Middle East & Africa: The market is expected to show the lowest growth due to limited access to treatment facilities and limited developments in technology.


Facial Rejuvenation Market Key Players



  • Allergan (Ireland)

  • Merz Pharma (Germany)

  • Galderma (Switzerland)

  • Lumenis (US)

  • Revance (US)

  • Contura Ltd (US)

  • Anika Therapeutics, Inc. (US)

  • Fibrocell Science, Inc. (US)

  • Cynosure, A Hologic Company (US)

  • Daewoong Co. Ltd (South Korea)

  • Sinclair Pharma (UK)

  • Teoxane Laboratories (Switzerland)

  • Suneva Medical (US)

  • Solta Medical, a Subsidiary of Bausch Health Companies (US)

  • SciVision Biotech Inc. (Taiwan)



Report Scope:

Report Attribute/Metric Details
  Market Size   USD 26.36 Billion
  CAGR 7.10% (2022-2030)
  Base Year  2021
  Forecast Period 2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product Type and By End-User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Allergan (Ireland), Merz Pharma (Germany), Galderma (Switzerland), Lumenis (US), Revance (US), Contura Ltd (US), Anika Therapeutics, Inc. (US), Fibrocell Science, Inc. (US), Cynosure, A Hologic Company (US), Daewoong Co. Ltd (South Korea), Sinclair Pharma (UK), Teoxane Laboratories (Switzerland), Suneva Medical (US), Solta Medical, a Subsidiary of Bausch Health Companies (US), and SciVision Biotech Inc. (Taiwan).
  Key Market Opportunities   The increasing popularity of facial rejuvenation over invasive cosmetic procedures is expected to increase the demand for procedures
  Key Market Drivers Cost-effective alternative to cosmetic surgeries. Rising demand for non-invasive aesthetic procedures. Increasing R&D expenditure by companies to develop advanced treatments


Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

The requirement for non-invasive aesthetic procedures is estimated to promote the global market.

By 2030, the market is anticipated to observe 7.10% CAGR in the impending period.

An income of USD 26.36 Billion is to be expected to spur the market.

The Americas regional market is estimated to gain a leadership position in the forecast period.

Anika Therapeutics, Inc. (US), Galderma (Switzerland), Revance (US), Contura Ltd (US), Lumenis (US), and Fibrocell Science, Inc. (US) are the frontrunners in the market.